{
  "id": "4cd332d19b086a26",
  "title": "STAT+: Pharmalittle: We\u2019re reading about an Eli Lilly deal, an Amgen acquisition, and much more",
  "description": "Eli Lilly is in advanced talks to acquire Ventyx Biosciences, which is developing pills for autoimmune conditions, for more than $1 billion",
  "content": "Eli Lilly is in advanced talks to acquire Ventyx Biosciences, which is developing pills for autoimmune conditions, for more than $1 billion",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/01/07/lilly-ventyx-nimbus-obesity-amgen-gsk-jpm-monsanto-covid/?utm_campaign=rss",
  "published_at": "2026-01-07T14:31:04+00:00",
  "fetched_at": "2026-01-08T00:23:56.998868+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about an Eli Lilly deal, an Amgen acquisition, and much more",
    "description": "Eli Lilly is in advanced talks to acquire Ventyx Biosciences, which is developing pills for autoimmune conditions, for more than $1 billion",
    "url": "https://www.statnews.com/pharmalot/2026/01/07/lilly-ventyx-nimbus-obesity-amgen-gsk-jpm-monsanto-covid/?utm_campaign=rss",
    "published": "2026-01-07T14:31:04+00:00",
    "source": "STAT"
  }
}